Not applicableUnknownNCT04360733What this trial is testingPrecision Immunology to Determine the Immune Response in Patients With COVID-19Who this might be right forSARS-CoV 2COVID University of Bonn 200
Not applicableStudy completedNCT04373148What this trial is testingUnderstanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19Who this might be right forCoronavirus Stanford University 316
Early research (Phase 1)WithdrawnNCT05167253What this trial is testingEvaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.Who this might be right forCOVID-19 United Biomedical Inc., Asia
Not applicableUnknownNCT05075499What this trial is testingImmune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and AlemtuzumabWho this might be right forMultiple Sclerosis Sheba Medical Center 70
Very early researchStudy completedNCT04936997What this trial is testingImmune Response to the COVID-19 VaccineWho this might be right forCovid19CancerMalignancy+1 more University of Arizona 20
Not applicableUnknownNCT04842305What this trial is testingMucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and VaccinationWho this might be right forCovid19 Lenanrt Friis-Hansen 500
Large-scale testing (Phase 3)Study completedNCT06374394What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 841
Not applicableStudy completedNCT04805216What this trial is testingCovid-19 Vaccine Response in Immunocompromised Haematology PatientsWho this might be right forCovid19Haematological DisordersImmune Suppression University Hospitals of North Midlands NHS Trust 75
Not applicableUnknownNCT05119738What this trial is testingImmune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active TreatmentWho this might be right forSars-CoV-2 Infection Pontificia Universidad Catolica de Chile 122
Not applicableWithdrawnNCT04409184What this trial is testingWhole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 InfectionWho this might be right forCOVIDSars-CoV2 Medical College of Wisconsin
Not applicableStudy completedNCT04745377What this trial is testingResponses to COVID-19 Vaccination in Patients With CancerWho this might be right forCancer Hellenic Cooperative Oncology Group 332
Not applicableStudy completedNCT04356586What this trial is testingImmune Response to Covid-19 in 300 Health Care Workers With Mild SymptomsWho this might be right forCOVID-19Serology Sciensano 287
Early research (Phase 1)Study completedNCT05685953What this trial is testingA Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 VaccineWho this might be right forCOVID-19 Respiratory InfectionCOVID-19 Vaccine Adverse Reaction Matti Sällberg 16
Large-scale testing (Phase 3)Study completedNCT04373291What this trial is testingUsing BCG Vaccine to Protect Health Care Workers in the COVID-19 PandemicWho this might be right forCOVID-19Non-specific Effects of VaccinesMorbidity+2 more Bandim Health Project 1,293
Not applicableActive Not RecruitingNCT05269888What this trial is testingCovid-19 Vaccine Immune Response in Multiple SclerosisWho this might be right forMultiple Sclerosis University Hospitals of North Midlands NHS Trust 240
Not applicableUnknownNCT03944603What this trial is testingLongitudinal Innate Immunity and Aging StudyWho this might be right forHealthy Older Adults Ages 60-89 University of Colorado, Denver 300
Not applicableActive Not RecruitingNCT06070961What this trial is testingProspective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceWho this might be right forFollicular Lymphoma Fondazione Italiana Linfomi - ETS 56
Not applicableStudy completedNCT05951920What this trial is testingLymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.Who this might be right forCOVID-19 Assistance Publique - Hôpitaux de Paris 12
Post-approval studies (Phase 4)Study completedNCT05778383What this trial is testingZinc Supplementation Impact in Acute COVID-19 Clinical OutcomesWho this might be right forZinc DeficiencySars-CoV-2 Infection Parc de Salut Mar 75
Not applicableStudy completedNCT04888793What this trial is testingImmune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort StudyWho this might be right forCovid19COVID-19 Vaccines Pontificia Universidad Catolica de Chile 260